Mardozia Pf (Χωρίσ Συντηρητικό) (Dorzolamide, Timolol)

Dorzolamide inhibits the enzyme carbonic anhydrase in the ciliary body of the eye, which reduces the production of aqueous humor. This decrease in fluid formation contributes to lower intra‑ocular pressure, a key factor in managing glaucoma.

The dosing regimen for Mardozia Pf is determined by the prescribing ophthalmologist based on the patient’s condition and response. Typically, one or two drops are instilled in each affected eye once or twice daily, but the exact schedule should follow the prescriber’s instructions.

Safety data for Mardozia Pf in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order Mardozia Pf, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Mardozia Pf combines a carbonic anhydrase inhibitor (dorzolamide) with a non‑selective beta‑blocker (timolol), offering dual mechanisms to reduce aqueous humor production. Compared with single‑agent drops, this combination can achieve greater intra‑ocular pressure reduction, potentially reducing the need for multiple separate medications.

Store Mardozia Pf at room temperature, below 25 °C. Keep the bottle in its original packaging, protect it from direct light and moisture, and ensure the cap is tightly closed to maintain sterility.

Mardozia Pf is applied as eye drops. The patient should wash hands, tilt the head back, pull down the lower eyelid to create a pocket, and instill the prescribed number of drops without touching the tip of the bottle to the eye or any surface.

Serious risks include severe allergic reactions, marked bradycardia or heart block, bronchospasm in susceptible individuals, and systemic hypotension. Patients should be instructed to seek immediate medical attention if they experience symptoms such as difficulty breathing, rapid heartbeat, or swelling of the face or throat.

Mardozia Pf should be avoided in patients with known hypersensitivity to dorzolamide, timolol, sulfonamides, or any component of the formulation. It is also contraindicated in individuals with severe bradycardia, advanced heart block, uncontrolled asthma, or chronic obstructive pulmonary disease.